Quadriceps tendon autograft for anterior cruciate ligament reconstruction: state of the art.


Journal

Journal of ISAKOS : joint disorders & orthopaedic sports medicine
ISSN: 2059-7762
Titre abrégé: J ISAKOS
Pays: England
ID NLM: 101680867

Informations de publication

Date de publication:
12 2022
Historique:
received: 08 05 2022
revised: 29 07 2022
accepted: 24 08 2022
pubmed: 13 9 2022
medline: 24 12 2022
entrez: 12 9 2022
Statut: ppublish

Résumé

The ideal graft for anterior cruciate ligament reconstruction (ACLR) continues to be debated. Although first described in 1984, use of the quadriceps tendon (QT) autograft has only recently gained popularity. The biomechanical properties of the QT autograft are favourable compared to bone-patellar tendon-bone (BPTB) and doubled hamstring (HS) grafts with a higher load to failure and a modulus of elasticity that more closely approximates the native anterior cruciate ligament (ACL). The QT graft can be harvested with or without a bone plug, as either a full thickness or a partial thickness graft, and even through minimally invasive techniques. The surgeon must be aware of potential harvest risks including patellar fracture or a graft that is of insufficient length. Numerous short-term studies have shown comparable results when compared to BPTB or hamstring HS autografts with similar graft failure rates, patient-reported outcomes. A major advantage of QT ACLR is reduced donor site morbidity compared to BPTB. However, some persistent quadriceps weakness after QT ACLR has also been reported. The current literature shows that use of the QT autograft for ACLR provides equivalent clinical results compared to other autografts with less donor site morbidity. However, future studies with longer follow-up and higher level of evidence are needed to identify specific populations where the QT may have additional advantage.

Identifiants

pubmed: 36096362
pii: S2059-7754(22)00085-2
doi: 10.1016/j.jisako.2022.08.010
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-172

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Bryce Clinger (B)

Department of Orthopaedics and Rehabilitation, University of New Mexico, Albuquerque, NM, 87131, USA.

John Xerogeanes (J)

Department of Orthopaedics, Emory University, Atlanta, GA, 30322, USA.

Julian Feller (J)

OrthoSport Victoria, Melbourne, 3121, Australia.

Christian Fink (C)

Gelenkpunkt, Innsbruck, 6020, Austria.

Armin Runer (A)

Department of Orthopaedics and Traumatology, Medical University of Innsbruck, Innsbruck, 6020, Austria.

Dustin Richter (D)

Department of Orthopaedics and Rehabilitation, University of New Mexico, Albuquerque, NM, 87131, USA.

Daniel Wascher (D)

Department of Orthopaedics and Rehabilitation, University of New Mexico, Albuquerque, NM, 87131, USA. Electronic address: dwascher@unm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH